These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 30987439)
1. Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunities. Mittal R; Pena SA; Zhu A; Eshraghi N; Fesharaki A; Horesh EJ; Mittal J; Eshraghi AA Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1312-1320. PubMed ID: 30987439 [TBL] [Abstract][Full Text] [Related]
2. Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss. Li L; Chao T; Brant J; O'Malley B; Tsourkas A; Li D Adv Drug Deliv Rev; 2017 Jan; 108():2-12. PubMed ID: 26796230 [TBL] [Abstract][Full Text] [Related]
3. Nanodelivery of antioxidant Agents: A promising strategy for preventing sensorineural hearing loss. Hajmohammadi Z; Bagher Z; Taghizadeh-Hesary F; Khodadadi M; Masror N; Asghari A; Valipour B; Seifalian A Eur J Pharm Biopharm; 2024 Sep; 202():114393. PubMed ID: 38992481 [TBL] [Abstract][Full Text] [Related]
4. Approaches for Ear-targeted Delivery Systems in Neurosensory Disorders to avoid Chronic Hearing Loss Mediated Neurological Diseases. Verma R; Vyas P; Kaur J; Javed MN; Sarafroz M; Ahmad M; Gilani SJ; Taleuzzaman M CNS Neurol Disord Drug Targets; 2022; 21(6):479-491. PubMed ID: 34477535 [TBL] [Abstract][Full Text] [Related]
5. Development of nanoparticle drug-delivery systems for the inner ear. An X; Zha D Nanomedicine (Lond); 2020 Aug; 15(20):1981-1993. PubMed ID: 32605499 [TBL] [Abstract][Full Text] [Related]
6. Blood-Labyrinth Barrier in Health and Diseases: Effect of Hormetic Nutrients. Cosentino A; Agafonova A; Modafferi S; Trovato Salinaro A; Scuto M; Maiolino L; Fritsch T; Calabrese EJ; Lupo G; Anfuso CD; Calabrese V Antioxid Redox Signal; 2024 Mar; 40(7-9):542-563. PubMed ID: 37565276 [No Abstract] [Full Text] [Related]
7. Drug delivery to the inner ear: strategies and their therapeutic implications for sensorineural hearing loss. Rivera T; Sanz L; Camarero G; Varela-Nieto I Curr Drug Deliv; 2012 May; 9(3):231-42. PubMed ID: 22283653 [TBL] [Abstract][Full Text] [Related]
8. Probucol-bile acid nanoparticles: a novel approach and promising solution to prevent cellular oxidative stress in sensorineural hearing loss. Wagle SR; Kovacevic B; Foster T; Ionescu CM; Jones M; Mikov M; Wise A; Mooranian A; Al-Salami H J Drug Target; 2024 Aug; 32(7):737-755. PubMed ID: 38758361 [TBL] [Abstract][Full Text] [Related]
9. Advancements in the studies of novel nanomaterials for inner ear drug delivery. Zhang L; Bai X; Wang R; Xu L; Ma J; Xu Y; Lu Z Nanomedicine (Lond); 2022 Aug; 17(20):1463-1475. PubMed ID: 36189895 [TBL] [Abstract][Full Text] [Related]
10. Disposition of nanoparticle-based delivery system via inner ear administration. Chen G; Zhang X; Yang F; Mu L Curr Drug Metab; 2010 Dec; 11(10):886-97. PubMed ID: 21208174 [TBL] [Abstract][Full Text] [Related]
11. LDL receptor-related protein 1 (LRP1), a novel target for opening the blood-labyrinth barrier (BLB). Shi X; Wang Z; Ren W; Chen L; Xu C; Li M; Fan S; Xu Y; Chen M; Zheng F; Zhang W; Zhou X; Zhang Y; Qiu S; Wu L; Zhou P; Lv X; Cui T; Qiao Y; Zhao H; Guo W; Chen W; Li S; Zhong W; Lin J; Yang S Signal Transduct Target Ther; 2022 Jun; 7(1):175. PubMed ID: 35680846 [TBL] [Abstract][Full Text] [Related]
12. Inner ear drug delivery for auditory applications. Swan EE; Mescher MJ; Sewell WF; Tao SL; Borenstein JT Adv Drug Deliv Rev; 2008 Dec; 60(15):1583-99. PubMed ID: 18848590 [TBL] [Abstract][Full Text] [Related]
13. Development of a drug delivery system for the inner ear using poly(amino acid)-based nanoparticles. Kim DK; Park SN; Park KH; Park CW; Yang KJ; Kim JD; Kim MS Drug Deliv; 2015 May; 22(3):367-74. PubMed ID: 24447111 [TBL] [Abstract][Full Text] [Related]
14. A novel nanoparticle delivery system for targeted therapy of noise-induced hearing loss. Kayyali MN; Wooltorton JRA; Ramsey AJ; Lin M; Chao TN; Tsourkas A; O'Malley BW; Li D J Control Release; 2018 Jun; 279():243-250. PubMed ID: 29673641 [TBL] [Abstract][Full Text] [Related]
15. Intratympanic delivery of oligoarginine-conjugated nanoparticles as a gene (or drug) carrier to the inner ear. Yoon JY; Yang KJ; Kim DE; Lee KY; Park SN; Kim DK; Kim JD Biomaterials; 2015 Dec; 73():243-53. PubMed ID: 26414408 [TBL] [Abstract][Full Text] [Related]
16. Probucol-bile acid based nanoparticles protect auditory cells from oxidative stress: an Wagle SR; Kovacevic B; Ionescu CM; Foster T; Jones M; Mikov M; Wise A; Mooranian A; Al-Salami H Ther Deliv; 2024 Apr; 15(4):237-252. PubMed ID: 38469721 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in therapeutics and drug delivery for the treatment of inner ear diseases: a patent review (2011-2015). Nguyen K; Kempfle JS; Jung DH; McKenna CE Expert Opin Ther Pat; 2017 Feb; 27(2):191-202. PubMed ID: 27855527 [TBL] [Abstract][Full Text] [Related]
18. Strategies for drug delivery to the human inner ear by multifunctional nanoparticles. Roy S; Glueckert R; Johnston AH; Perrier T; Bitsche M; Newman TA; Saulnier P; Schrott-Fischer A Nanomedicine (Lond); 2012 Jan; 7(1):55-63. PubMed ID: 22106854 [TBL] [Abstract][Full Text] [Related]
19. Challenges and opportunities in developing targeted molecular imaging to determine inner ear defects of sensorineural hearing loss. Kayyali MN; Wright AC; Ramsey AJ; Brant JA; Stein JM; O'Malley BW; Li D Nanomedicine; 2018 Feb; 14(2):397-404. PubMed ID: 29074310 [TBL] [Abstract][Full Text] [Related]
20. A prestin-targeting peptide-guided drug delivery system rearranging concentration gradient in the inner ear: An improved strategy against hearing loss. Wang X; Zhou Z; Yu C; He K; Sun L; Kou Y; Zhang M; Zhang Z; Luo P; Wen L; Chen G Eur J Pharm Sci; 2023 Aug; 187():106490. PubMed ID: 37295658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]